07:47 EDT Vigil Neuroscience (VIGL) files to sell 5.38M shares of common stock for holders
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VIGL:
- Vigil Neuroscience Inc.: Promising Biomarker Data and Strategic Advancements Justify Buy Rating
- Vigil Neuroscience price target lowered to $14 from $17 at H.C. Wainwright
- Vigil Neuroscience price target lowered to $13 from $24 at Wedbush
- Vigil Neuroscience Faces Market Risks from Preferred Stock Issuance and Potential Share Dilution
- Promising Clinical Progress and Strategic Advancements Justify Buy Rating for Vigil Neuroscience